New research finds patient satisfaction with GP services has dropped since pre-pandemic
March 31, 2022GP leaders have said that it is ‘unsurprising’ that more people are dissatisfied with the NHS than are satisfied, and …
FDA approval of Cabenuva for adolescents living with HIV
March 31, 2022Business Services
ViiV Healthcare, the global specialist HIV company, today announced the FDA approval of Cabenuva (cabotegravir, rilpivirine), for the treatment of …
Carteyva receives IND approval for clinical trial in second-line large b-cell lymphoma
March 31, 2022Business Services
An investigational new drug (IND) clearance from the National Medical Products Administration (NMPA) of China, for a pivotal clinical trial …
250,000 with diabetes to benefit from real time information after updated NICE recommendations
March 31, 2022Business Services
Over 250,000 people living with type 1 diabetes are set to be offered new technology to help them manage their …
Kesimpta-treated adults with multiple sclerosis not at risk of severe COVID-19
March 30, 2022Business Services
The peer-reviewed journal Neurology and Therapy has published new data on COVID-19 infections in people living with remitting multiple sclerosis …
Carthera’s SonoCloud demonstrates potential in Alzheimer’s patients
March 30, 2022Business Services
Carthera has announced the publication of results in the Alzheimer’s Research & Therapy Journal, from an investigator-sponsored trial evaluating the …
Iktos announces a collaboration with Ono for new drug design
March 30, 2022Research and Development
Iktos, a company specialised in AI for new drug design today announced a collaboration agreement with Ono Pharmaceuticals, on innovative …
$24 million in grants to help end HIV epidemic across the globe
March 30, 2022Research and Development
Gilead Sciences announced $24 million in grants to help reduce health disparities, improve access to quality healthcare, advance medical education, …
Margaret Keegan joins RQM+ as new CEO
March 29, 2022RQM+, a world leading provider of regulatory, clinical and quality solutions to the MedTech industry, announced the appointment of life …
Injecting real-world data into every day clinical trials – RWE and RWD
March 29, 2022The past two years have seen unprecedented pressure on healthcare systems, its workers, and clinical research as a whole. COVID-19 …
Preparation Preconditions: What measures are needed to combat another pandemic?
March 29, 2022Could we have foreseen the damage caused by the COVID-19 pandemic? This is a central question that has plagued biopharma …
CHMP recommends approval of Janssen’s first CAR-T therapy
March 29, 2022Manufacturing and Production
Johnson & Johnson have announced the CHMP recommendation of marketing authorisation of ciltacabtagene autoleucel (cilta-cel) for the treatment of adults …
Telix granted FDA orphan drug designation for bone marrow conditioning treatment
March 29, 2022Manufacturing and Production
The FDA has granted Orphan Drug Designation (ODD) for TLX66, for conditioning treatment prior to hematopoietic stem cell transplant (HSCT). …
Japan: drug approved for treatment of life-threatening bleeding
March 29, 2022Manufacturing and Production
AstraZeneca has announced that Ondexxya has become the first approved medicine in Japan to reverse the anticoagulant effect of Factor …
BIMZELX effective for moderate to severe plaque psoriasis treatment
March 29, 2022Manufacturing and Production
UCB has revealed results from its Phase III/IIIb trials of BIMZELX (bimekizumab) for the treatment of adults with moderate to …
NICE does not recommend icosapent ethyl for prevention of cardiovascular events
March 28, 2022Sales and Marketing
NICE has published further draft guidance for public consultation which does not recommend VAZKEPA (icosapent ethyl) for reducing the risk …
FDA approve oral solution for rare childhood epilepsy
March 28, 2022Sales and Marketing
UCB has announced that FINTEPLA® (fenfluramine) oral solution CIV has been approved by the FDA for the treatment of seizures …
EMA review first novel gene therapy candidate for haemophilia B
March 28, 2022Sales and Marketing
CSL Behring has today announced that the EMA has accepted the Marketing Authorising Application for etranacogene dezaparvovec (EtranaDez), under its …
Pregnant women to receive life-saving pre-eclampsia check on NHS
March 28, 2022Sales and Marketing
A life-saving blood test that can help diagnose suspected preterm pre-eclampsia has been recommended by NICE, and this is to …
After pressure from patients, ALS drug reviewed by FDA
March 25, 2022Medical Communications
The FDA is meeting next week to review a drug closely watched for ALS, also known as Lou Gehrig’s disease, …
